WCRI & WIHV scientists receive over $2.4M in research funding
Scientists at Women’s College Research Institute (WCRI) and the Women’s College Hospital Institute for Virtual Care and Health System Solutions (WIHV) received support for six exciting research programs during the latest grant competition from the Canadian Institutes of Health Research (CIHR). In total, they received over $2.4M in research funding for periods ranging from one to five years.
CIHR funding is very competitive, with a national success rate of 21 per cent during the fall competition. WCRI’s success rate was three times higher than the national average at 60 per cent. Three of our funded grants were also ranked first in their respective committees.
Congratulations to our scientists on their successfully funded research projects!
Dr. Simone Vigod
A randomized clinical trial of at-home transcranial Direct Current Stimulation (tDCS) for depression in pregnancy
Dr. Vigod received approximately $1.018M to conduct a large randomized clinical trial (RCT) to evaluate tDCS for depression in pregnancy, following the success of the pilot project. tDCS is a non-invasive brain stimulation treatment that does not pose a risk to a developing fetus. It has the potential to be a mainstream treatment for depression in pregnancy.
Laura Desveaux, PhD
Optimizing audit and feedback: Personalizing delivery according to team differences
Desveaux received approximately $593,000 to understand how to adapt, audit and feedback interventions by examining the individual and team-level factors that drive variation in performance. Insights from the project will inform revisions to the GEneral Medicine INpatient Initiative (GEMINI), which identifies physician-level differences in processes of care, resource utilization and patient outcomes.
Dr. Lihi Eder
Dietary Interventions in psoriatic arthritis (DIPsA): A Randomized, controlled, pilot trial
Dr. Eder received approximately $352,000 to study the role of dietary interventions as an adjunct therapy for psoriatic arthritis – a chronic inflammatory musculoskeletal disease. Dr. Eder and her team will conduct a clinical trial of two dietary interventions – the Mediterranean diet and low-fat/low-calorie diet.
Mina Tadrous, PharmD, PhD
Real-world effectiveness and cost-effectiveness of novel hepatitis C treatments
Tadrous was awarded approximately $325,000 to assess the real-world impact of funding direct-acting antivirals (DAAs) – used to treat chronic hepatitis C infection – on access, patient outcomes and cost. The data obtained aims to measure patterns of use across Ontario and inform future negotiations for drug prices across the country.
Dr. Noah Ivers
Design and evaluation of a system-wide surveillance system for late effects of treatment in childhood cancer survivors
Dr. Ivers received $100,000 to address the health gap for survivors of childhood cancer who are at high risk of developing new cancers and/or heart problems as a result of their cancer treatment. Dr. Ivers and his team will build a system in Ontario to ensure that these individuals continue to get the follow-up care they need when they transition from the intensive childhood cancer care system to the routine healthcare system in adulthood.
Dr. An-Wen Chan
Patterns of care and outcomes for localized melanoma: Population-based cohort study
Dr. Chan received $100,000 to investigate the patterns of care for diagnosing and treating melanoma across Ontario, including the type of doctor involved and the timing of surgery. The findings will provide guidance to health practitioners in creating a diagnosis and treatment plan for patients with melanoma.